Publications by authors named "Prodromos Anthopoulos"

Claim this Profile
I
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Daniel Feldman, Davide Cao, Samantha Sartori, Zhongjie Zhang, Christian Hengstenberg, Prodromos Anthopoulos

Catheter Cardiovasc Interv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.
Stefan Schreiber, Peter M Irving, Ala I Sharara, María Dolores Martín-Arranz, Xavier Hébuterne, Prodromos Anthopoulos

Aliment Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Victor Razuk, Anton Camaj, Davide Cao, Johny Nicolas, Christian Hengstenberg, Prodromos Anthopoulos

Catheter Cardiovasc Interv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.
Jaya Chandrasekhar, Samantha Sartori, Roxana Mehran, Melissa Aquino, Birgit Vogel, Prodromos Anthopoulos

Clin Res Cardiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
Anton Camaj, Bimmer E Claessen, Roxana Mehran, Matias B Yudi, David Power, Prodromos Anthopoulos

Catheter Cardiovasc Interv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
Robert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, Samantha Sartori, Davide Cao, Prodromos Anthopoulos

Catheter Cardiovasc Interv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.
Ridhima Goel, David Power, Didier Tchetche, Rishi Chandiramani, Paul Guedeney, Prodromos Anthopoulos

Int J Cardiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.
David Power, Ulrich Schäfer, Paul Guedeney, Bimmer E Claessen, Samantha Sartori, Prodromos Anthopoulos

Catheter Cardiovasc Interv· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Vincent Johan Nijenhuis, Jurrien Maria Ten Berg, Christian Hengstenberg, Thierry Lefèvre, Stephan Windecker, Prodromos Anthopoulos

Am J Cardiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.
Tomasz Rakowski, Dariusz Dudek, Arnoud van 't Hof, Jurrien Ten Berg, Louis Soulat, Prodromos Anthopoulos

Eur Heart J Acute Cardiovasc Care· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Christian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, Thierry Lefevre, Ghada Mikhail, Prodromos Anthopoulos

Catheter Cardiovasc Interv· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Axel Linke, Jaya Chandrasekhar, Samantha Sartori, Thierry Lefevre, Eric van Belle, Prodromos Anthopoulos

Catheter Cardiovasc Interv· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.
Robert Jan van Geuns, Georgios Sideris, Niels Van Royen, Rami El Mahmoud, Roberto Diletti, Prodromos Anthopoulos

EuroIntervention· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.
Enrico Fabris, Sinem Kilic, Arnoud W J Van't Hof, Jurrien Ten Berg, Ana Ayesta, Prodromos Anthopoulos

JAMA Cardiol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study.
Eric Van Belle, Christian Hengstenberg, Thierry Lefevre, Christian Kupatt, Nicolas Debry, Prodromos Anthopoulos

J Am Coll Cardiol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
George D Dangas, Thierry Lefèvre, Christian Kupatt, Didier Tchetche, Ulrich Schäfer, Prodromos Anthopoulos

J Am Coll Cardiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.
Martial Hamon, Pierre Coste, Arnoud Van't Hof, Jurrien Ten Berg, Peter Clemmensen, Prodromos Anthopoulos

Circ Cardiovasc Interv· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography).
Peter Clemmensen, Sebastian Wiberg, Arnoud Van't Hof, Efthymios N Deliargyris, Pierre Coste, Prodromos Anthopoulos

JACC Cardiovasc Interv· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on myocardial reperfusion using the M-Guard stent in primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Prodromos Anthopoulos, Ioannis Alexanian, Georgia Karabela, Loukas Pappas, Ioannis Antonellis

Int J Cardiol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
Dimitrios Alexopoulos, Vassilios Gkizas, Sotirios Patsilinakos, Ioanna Xanthopoulou, Christos Angelidis, Prodromos Anthopoulos

J Am Coll Cardiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and angiographic results with novel polysulfone polymer coating paclitaxel eluting stent in real-world clinical practice: a clinical centre registry.
Gerasimos Gavrielatos, Prodromos L Anthopoulos, Loukas K Pappas, Isidoros Gavaliatsis, Anastasios Salachas

Med Sci Monit· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of open-chest cardiac resuscitation on mitral regurgitant flow: an on-line transesophageal echocardiographic study in dogs.
Dimitrios N Chrissos, Panagiotis G Antonatos, Dimitrios Z Mytas, Andreas A Katsaros, Prodromos L Anthopoulos, Lambros P Anthopoulos

Hellenic J Cardiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient dose in cardiac radiology.
Andreas I Stratis, Prodromos L Anthopoulos, Isidoros P Gavaliatsis, Georghios P Ifantis, Anastasios I Salahas

Hellenic J Cardiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe accordion effect: Myocardial ischemia due to wire complication during percutaneous coronary intervention: A case report.
Gerasimos Gavrielatos, Loukas K Pappas, Prodromos Anthopoulos, Anastasios Salachas, Georgios Ifantis

Cases J· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success, safety, and efficacy of implantation of diamond-like carbon-coated stents.
Anastasios Salahas, Antonios Vrahatis, Ilias Karabinos, Ioannis Antonellis, Georgios Ifantis, Prodromos Anthopoulos

Angiology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis